Cytek Biosciences (CTKB) EPS (Diluted) (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) EPS (Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn |
| 10 | Cytek Biosciences | 576.60 Mn | 510.90 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.52% |
| Dec 31, 2025 | -703.35% |
| Sep 30, 2025 | 2.35% |
| Jun 30, 2025 | 50.49% |
| Mar 31, 2025 | -220.33% |
| Dec 31, 2024 | 941.82% |
| Sep 30, 2024 | 108.93% |
| Jun 30, 2024 | -68.47% |
| Mar 31, 2024 | -215.84% |
| Dec 31, 2023 | 185.80% |
| Sep 30, 2023 | -46.85% |
| Jun 30, 2023 | 35.74% |
| Mar 31, 2023 | -297.26% |
| Dec 31, 2022 | 112.05% |
| Sep 30, 2022 | 369.95% |
| Jun 30, 2022 | 70.52% |
| Mar 31, 2021 | -83.83% |
| Dec 31, 2020 | -62.11% |
| Sep 30, 2020 | -23.71% |